廣泰國際控股(00844.HK):最終控股股東永泰科技重組申請獲南京中院受理
格隆匯7月12日丨廣泰國際控股(00844.HK)公佈,於2021年7月9日,公司獲集團控股股東永泰集團吿知,其主要股東永泰科技已於2021年6月向南京中級法院申請進行重組。南京中級法院已於2021年7月6日作出裁決,受理永泰科技的重組申請。隨着重組申請獲受理,永泰科技已進入解決債務的新階段。
於該公吿日期,(i)永泰集團為集團的控股股東,透過竣豐國際及竣豐投資間接持有公司全部已發行股本的52.73%;及(ii)永泰科技持有永泰集團全部股權的約96.98%。
於該公吿日期,公司並無有關重組的任何詳情。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.